Hepion Pharmaceuticals In... (HEPA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.45
-0.02 (-5.26%)
At close: Jan 15, 2025, 12:21 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -0.26 | -0.54 | -2.45 | -1.04 | -1.56 | -0.38 | -1.86 | -2.27 | -1.66 | -7.7 | -2.69 | -328.83 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.77 | 0.46 | 0.86 | 0.52 | 0.70 | 1.84 | 7.53 | 3.73 | 21.36 | 32.13 | -4.85 | -1.97K |
P/FCF Ratio | -0.31 | -0.65 | -2.56 | -1.3 | -1.44 | -0.23 | -3.4 | -1.76 | -1.7 | -11.33 | -10.31 | -3.48M |
P/OCF Ratio | -0.31 | -0.65 | -2.57 | -1.31 | -1.45 | -0.23 | -3.4 | -1.76 | -1.7 | -11.42 | -10.43 | -3.48M |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.00 | 0.00 | 0.02 | 0.05 | 0.73 | n/a | n/a | 0.01 | n/a | n/a | -0.71 |
Quick Ratio | 3.31 | 7.16 | 11.88 | 9.15 | 8.94 | 1.04 | 2.33 | 4.48 | 1.55 | 2.71 | 4.32 | 0.38 |
Current Ratio | 3.31 | 7.16 | 11.88 | 9.15 | 8.94 | 1.04 | 2.33 | 4.48 | 1.55 | 2.71 | 4.32 | 0.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -5.12K | -4.48K | -3.43K | -645.11 | -14 | -43.03 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -6.72 | -0.85 | -0.35 | -0.5 | -0.45 | -4.78 | -4.06 | -1.64 | -12.9 | -4.17 | 1.80 | 6.00 |
Return on Assets (ROA) | -2.7 | -0.7 | -0.32 | -0.42 | -0.34 | -1.15 | -1.33 | -0.81 | -1.3 | -2.67 | -2.64 | -9.72 |
Return on Capital (ROIC) | -3.78 | -0.87 | -0.32 | -0.46 | -0.41 | -2.73 | -2.43 | -1.36 | -2.59 | -4.06 | -1.08 | 5.99 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |